Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burn

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Microbial & Comparative Genomics|January 1, 1996
A 2.5 kb polypyrimidine tract in the PKD1 gene contains at least 23 H-DNA-forming sequencesT J Van Raay, T C Burn, T D Connors, et al.
Genome Research|June 1, 1996
Generation of a transcriptional map for a 700-kb region surrounding the polycystic kidney disease type 1 (PKD1) and tuberous sclerosis type 2 (TSC2) disease genes on human chromosome 16p3.3T C Burn, T D Connors, T J Van Raay, et al.
Genomics|December 24, 1997
A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genesR J Hu, M P Lee, T D Connors, et al.
Genetic Testing and Molecular Biomarkers|March 30, 2013
Validation of standards for quantitative assessment of JAK2 c.1849G>T (p.V617F) allele burden analysis in clinical samplesPaul Collier, Keyur Patel, Paul Waeltz, et al.
Annals of Hematology|May 1, 2017
Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE studyAlessandro Maria Vannucchi, Srdan Verstovsek, Paola Guglielmelli, et al.
Cancer Discovery|November 21, 2020
Clinicogenomic Analysis of <i>FGFR2</i>-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to PemigatinibIan M Silverman, Antoine Hollebecque, Luc Friboulet, et al.
Plos One|April 22, 2015
A two-year participatory intervention project with owners to reduce lameness and limb abnormalities in working horses in Jaipur, IndiaChristine E Reix, Amit K Dikshit, Jo Hockenhull, et al.
Endocrinology|September 20, 2002
Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell typesJeffrey C Webster, Reid M Huber, Rebecca L Hanson, et al.
Current Chemical Genomics|June 18, 2010
Phosphorylation State-Dependent High Throughput Screening of the c-Met KinaseElham Behshad, Ronald M Klabe, Alexander Margulis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 12, 2003
Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivoPhillip C C Liu, Reid Huber, Mark D Stow, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Microbial & Comparative Genomics|January 1, 1996
A 2.5 kb polypyrimidine tract in the PKD1 gene contains at least 23 H-DNA-forming sequencesT J Van Raay, T C Burn, T D Connors, et al.
Genome Research|June 1, 1996
Generation of a transcriptional map for a 700-kb region surrounding the polycystic kidney disease type 1 (PKD1) and tuberous sclerosis type 2 (TSC2) disease genes on human chromosome 16p3.3T C Burn, T D Connors, T J Van Raay, et al.
Genomics|December 24, 1997
A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genesR J Hu, M P Lee, T D Connors, et al.
Genetic Testing and Molecular Biomarkers|March 30, 2013
Validation of standards for quantitative assessment of JAK2 c.1849G>T (p.V617F) allele burden analysis in clinical samplesPaul Collier, Keyur Patel, Paul Waeltz, et al.
Annals of Hematology|May 1, 2017
Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE studyAlessandro Maria Vannucchi, Srdan Verstovsek, Paola Guglielmelli, et al.
Cancer Discovery|November 21, 2020
Clinicogenomic Analysis of <i>FGFR2</i>-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to PemigatinibIan M Silverman, Antoine Hollebecque, Luc Friboulet, et al.
Plos One|April 22, 2015
A two-year participatory intervention project with owners to reduce lameness and limb abnormalities in working horses in Jaipur, IndiaChristine E Reix, Amit K Dikshit, Jo Hockenhull, et al.
Endocrinology|September 20, 2002
Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell typesJeffrey C Webster, Reid M Huber, Rebecca L Hanson, et al.
Current Chemical Genomics|June 18, 2010
Phosphorylation State-Dependent High Throughput Screening of the c-Met KinaseElham Behshad, Ronald M Klabe, Alexander Margulis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 12, 2003
Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivoPhillip C C Liu, Reid Huber, Mark D Stow, et al.
Pageof 13